NIKA.US Nika BioTechnology Inc

Healthcare Pharmaceuticals USA Stocks
0.3500 USD
Close of Nov 14, 2026
0.2000 0.7690
Market cap
USD 369M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NIKA.US undervalued?

Graham number

The Graham number of Nika BioTechnology Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nika BioTechnology Inc fundamental analysis

No fundamental analysis for Nika BioTechnology Inc yet.

Nika BioTechnology Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nika BioTechnology Inc

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorpo…

Full company profile